Endometriosis rekurens
Abstract
Abstrak. Endometriosis rekurens merupakan kekambuhan endometriosis dengan manifestasi nyeri, secara klinis atau pemeriksaan ultrasonografi ditemukan adanya lesi endometriotik dan peningkatan berulang dari marker CA 125 setelah operasi. Atau beberapa peneliti menyatakan bahwa endometriosis rekurens berdasarkan pada adanya bukti kekambuhan yang ditemukan pada saat operasi berulang dilakukan. Endometrioisis rekurens ditemukan dengan insiden rata-rata sekitar 20% pada 2 tahun pertama setelah operasi dan mencapai angka 50% pada 5 tahun berikutnya. Endometriosis rekurens meningkat dari waktu ke waktu dengan angka insiden kekambuhan yang bervariasi yang tergantung pada banyak faktor. Insiden endometriosis rekurens tergantung pada tipe lesi endometriosis, stadium, keterampilan ahli bedah dan tehnik operasi serta dosis dan durasi pengobatan pasca operasi. Untuk itu sangat diperlukan pengobatan secara teratur dan berkepanjangan setelah pasien menjalani operasi bedah untuk mancegah endometriosis rekurens. Sehingga endometriosis rekurens saat ini telah menjadi perhatian para klinisi dan memerlukan penanganan yang optimal dan komprehensif.
Kata kunci: Endometriosis Rekurens, Insiden, Penatalaksanaan
Abstract. Recurrence endometriosis is defined as endometriosis with painful symptoms, endometriotic lesions, and recurring elevations of the CA 125 marker after surgery was discovered clinically or ultrasonographically. Alternatively, other researchers claim that endometriosis recurs based on evidence of recurrence discovered through repeated surgery. Recurrent endometriosis is diagnosed at a rate of about 20% in the first two years after surgery, increasing to 50% in the next five years. Recurrent endometriosis becomes more common over time, with the rate of recurrence varying depending on a variety of circumstances. Recurrent endometriosis is determined by the type of endometrial lesion, stage, surgeon skill and surgical method, as well as the dose and length of postoperative treatment. For this reason, to avoid recurring endometriosis, the patient must receive consistent and long-term care after surgery. As a result, recurring endometriosis has become a source of concern for clinicians, necessitating the most effective and complete therapy.
Keywords: Recurrent Endometriosis, Incidence, Management
Keywords
References
Hoyle A Puckett Y. Endometrioma. Treasure Island (FL): StatPearls Publishing. 2021.
Guo S. Recurrence of endometriosis and its control. Oxford Univ Press behalf Eur Soc Hum Reprod Embryol. 2009;15(4):441–61.
Muneyyirci-Delale O, Anopa, Jenny1. Parazzini F, Esposito G, Tozzi L, Noli S BSE of endometriosis and its comorbidities. EJOGRB [Internet]. 2017;209:3–7. A from: http://dx. doi. org/10. 1016/j. ejogrb. 2016. 04. 02., Charles C, Mathur D, Parris R, Cutler JB, et al. Medical management of recurrent endometrioma with long-term norethindrone acetate. Int J Womens Health. 2012;4(1):149–54.
Ceccaroni M, Bounous V E, Clarizia R, Mautone D, and Mabrouk M. Recurrent endometrisis: a battle against an unknown enemy. The European Journal of Contraception & Reproductive Health Care. 2019.Available from: https://doi.org/10.1080/13625187.2019.1662391
Küçükbaş M, Eken MK, İlhan G, Şenol T, Kapudere B. Which factors are associated with the recurrence of endometrioma after cystectomy ? J Obstet Gynaecol. 2017;3615(October).
Gurkan Bozdag. Recurrence of endometriosis : risk factors, mechanisms and biomarkers. Future Medicine Ltd. Department of Obstetrics & Gynaecology, School of Medicine, Hacettepe University, Ankara, Turkey; 2015.
Modarresi M, Mehdizadehkashi A, Chaichian S, Ataei M,
Ahmadi-Pishkuhi M. Sonographic assessment of ovarian endometrioma recurrence six months after laparoscopic cystectomy in patients with endometriosis. Shiraz E Med J. 2020;21(3).
He ZX, Sun TT, Wang S, Shi HH, Fan QB, Zhu L, et al. Risk Factors for Recurrence of Ovarian Endometriosis in Chinese Patients Aged 45 and Over. Chin Med J (Engl). 2018;131(11).
Selcuk S, Cam C, Koc N, Kucukbas M, Ozkaya E, Eser A, et al. Evaluation of risk factors for the recurrence of ovarian endometriomas. Eur J Obstet Gynecol Reprod Biol [Internet]. 2016;203:56–60. Available from: http://dx.doi.org/10.1016/j.ejogrb.2016.05.008
Porpora MG, Pallante D, Ferro A, Crisafi B, Bellati F, Benedetti Panici P. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril [Internet]. 2010;93(3):716–21. Available from: http://dx.doi.org/10.1016/j.fertnstert.2008.10.018
Konar H. DC Dutta’s Textbook of Gynecology. 7th ed. New Delhi: Jaypee brothers Medical Publisher; 2016.
Ceccaroni M, Bounous VE, Clarizia R, Mautone D, Mabrouk M. Recurrent endometriosis: a battle against an unknown enemy. Eur J Contracept Reprod Heal Care [Internet]. 2019;24(6):464–74. Available from: https://doi.org/10.1080/13625187.2019.1662391
Koshiba A, Mori T, Okimura H, Akiyama K, Kataoka H, Takaoka O, et al. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries. Japan Soc Obstet Gynecol Res. 2018;1–7.
Zhu SY, Wu YS, Gu ZY, Zhang J, Jia SZ, Shi JH, et al. Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin- releasing hormone agonist with or without levonorgestrel intrauterine system insertion. Arch Gynecol Obstet [Internet]. 2021;303(2):533–9. Available from: https://doi.org/10.1007/s00404-020-05843-5
Li XY, Chao XP, Leng JH, Zhang W, Zhang JJ, Dai Y, et al. Risk factors for postoperative recurrence of ovarian endometriosis: Long-term follow-up of 358 women. J Ovarian Res. 2019;12(1):1–10.
Wacharachawana S, Phaliwong P, Prommas S, Smanchat B, Bhamarapravatana K, Suwannarurk K. Recurrence Rate and Risk Factors for the Recurrence of Ovarian Endometriosis after Laparoscopic Ovarian Cystectomy. Biomed Res Int. 2021;2021:10–4.
Vannuccini S, Reis FM, Coutinho LM, Lazzeri L, Centini G, Petraglia F. Surgical treatment of endometriosis: prognostic factors for better quality of life. Gynecol Endocrinol [Internet]. 2019;35(11):1010–4. Available from: https://doi.org/10.1080/09513590.2019.1616688
DOI: 10.24815/jks.v22i4.24732
Refbacks
- There are currently no refbacks.